Neutropenia  >>  epirubicin  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT02996617: PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia

Unknown status
4
240
RoW
rhG-CSF regimen, Pegylated rhG-CSF regimen
Shandong Provincial Hospital
Lymphoma,Non-Hodgkin
11/18
12/18
ELEGANT, NCT02549677: Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer

Completed
4
294
RoW
Epirubicin, anthracycline, Docetaxel, taxotere, cyclophosphamide
Ruijin Hospital
Breast Neoplasms
03/20
03/20

Download Options